Font Size: 

Drug-resistant tuberculosis continues to increase so that at present Tuberculosis is still a global health problem. In 2017 there were 558,000 incidences of drug-resistant cases from the 14 million prevalence of TB cases in the world. Patient compliance in the treatment of drug-resistant tuberculosis will increase the patient's cure rate and prevent the spread of MDR TB bacteria in the community. The purpose of this study was to determine the patient's determinants of adherence in undergoing a period of TB-RO treatment in TBC-RO treatment
hospitals in Aceh. This was a cross-sectional study was conducted at Poli TB MDR RSUD dr.Zainoel Abidin Banda Aceh, RSUD Tgk.Chiek Di Tiro Pidie and RSUD Cut Mutia North Aceh, from July 11 to Sept 15, 2019. A sample of 70 TB MDR patients was selected by saturated sampling. The dependent variable was the patient compliance. The independent variables were patient motivation, side effects of OAT, family support and health services. The data were collected using questionnaires and analyzed by multiple logistic regression. The patient compliance of the treatment drug resistant was influenced by patient motivation
(OR = 26,250; p = 0.000) and side effects of OAT (OR= 29,750; p= 0.013). The patient compliance was assosiated with family support (p= 0,010) and health services (p=0,002). The patient compliance of the treatment drug-resistant was influenced by patient motivation and side effects of OAT

compliance; TBC-RO; motivation; side effects of OAT; family support; health services